BioClinica Announces eHealth App xChange
NEWTOWN, Pa., Sept. 2, 2015 – BioClinica®, Inc., a specialty clinical trials technology and services provider today announced the creation of the eHealth App xChangeTM, an alliance channel for disruptive technology innovation across life sciences and healthcare. BioClinica’s eHealth App xChange provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica’s eHealth Cloud™.
The App xChange is a key component of the expanding BioClinica Partner Alliance program, a strategic priority led by eClinical President Mukhtar Ahmed. “BioClinica has a culture of innovation within clinical research,” said Ahmed. “BioClinica’s eHealth App xChange enables research communities to leverage an ecosystem of integrated mobile and cloud applications for unique patient and consumer engagement, digital medicine, biosensor and scientific analytic capabilities, thereby accelerating pre- and post-approval research while creating efficiency and quality benefits.”
Ahmed explained, “Our approach introduces pragmatic industry innovation and provides our customers with an integrated and highly interoperable platform that extends across the entire healthcare research landscape.”
BioClinica Global Product Development Senior Vice President Andrew Masters said, “Healthcare research applications like these are a natural fit with our core products and extend the BioClinica platform with source data capture, point of care, electronic patient record, workflow and safety offerings.” Masters added, “Our App xChange is an incubator and growth engine for niche technology providers and individual app developers, and we welcome new partners as BioClinica continues to lead industry innovation within the regulated clinical trial space.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
